Command Palette

Search for a command to run...

ACUTAAS
1484.6(+0.92%)
1W: -2.19%

Peers

Snapshot Summary

Acutaas Chemicals Ltd. shows promising revenue growth but struggles with high valuation metrics compared to peers. The company is outperformed by several competitors in profitability and efficiency metrics, positioning it as a sector laggard despite its growth potential.

  • • Acutaas Chemicals Ltd. has a high revenue growth rate but a high PE ratio, indicating overvaluation.
  • • Cipla Ltd. stands out as a value pick due to its low PE and high profitability.
  • • Divi's Laboratories Ltd. shows concerning growth patterns despite high margins.
  • • Cipla Ltd.: Lowest PE at 23.73 and strong ROE of 16.63, marking it as a value pick with attractive profitability.
  • • Dr. Reddy's Laboratories Ltd.: Strong profitability metrics with a PE of 15.50 and high ROE of 21.76, making it a strong overall performer.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
ACUTAAS₹1,413.30₹11,570.53Cr72.5220.14%0.01
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02
Explore
Watchlists
Chat
Portfolio